查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598450

組織銀行市場：按產品、應用程式和最終用戶分類 - 全球預測 2025-2030 年

Tissue Banking Market by Product (Consumables, Equipment), Application (Cosmetics, Medical research, Therapeutics), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年機構銀行市場估值為338.1億美元，預計2024年將達到371.3億美元，複合年成長率為9.91%，到2030年將達到655.4億美元。

範圍和定義包括出於治療和研究目的而收集、處理、儲存和分配人體組織。這個過程對於再生醫學、癌症治療和移植等應用至關重要，並且是生物醫學研究的重要資源。組織庫在確保及時獲取符合品質和安全標準的組織方面發揮關鍵作用。最終用途範圍包括醫院、研究機構和生物製藥公司，每個公司都將組織用於特定用途，從直接患者治療到高級醫學研究和新治療方法的開發。

主要市場統計
基準年[2023] 338.1億美元
預測年份 [2024] 371.3億美元
預測年份 [2030] 655.4億美元
複合年成長率（%） 9.91%

影響組織庫市場的主要成長要素包括生物技術的進步、再生醫學需求的增加以及需要先進治療解決方案的慢性病盛行率的上升。政府促進組織研究的措施以及製藥公司增加研發投資的措施進一步支持了這一成長。一個顯著的機會在於醫療保健基礎設施改善和組織輸送意識提高所推動的新興市場的擴張。為了利用這一優勢，企業應專注於開發具有成本效益和高效的組織保存技術，提高組織工程產品的可靠性，並與學術和研究機構形成策略聯盟。

影響市場成長的挑戰包括管理組織銀行業務的嚴格法律規範以及有關組織提供和使用的道德問題。組織保存和長期保存的技術障礙也構成了重大挑戰。低溫保存方法的創新、組織處理的自動化以及用於資料管理的生物銀行軟體的開發為研究和業務成長提供了有前景的領域。

這個市場的特點是監管和道德考慮以及快速技術進步之間複雜的相互作用。因此，企業在投資尖端研發的同時必須優先考慮遵守監管標準。與監管機構合作、培訓投資以及有關紙巾產品的公眾意識宣傳活動是促進市場擴張和解決當前限制的推薦策略。

市場動態：揭示快速發展的機構銀行市場的關鍵市場洞察

供給和需求的動態交互作用正在改變機構銀行市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球生物樣本庫的興起
    • 政府努力改善醫療機構的醫療設施
    • 移植醫學的快速發展和人體組織的使用不斷增加
  • 市場限制因素
    • 在受控環境中保存活組織的高成本
  • 市場機會
    • 由於藥物分析的重大進步，組織保存變得更加複雜
    • 醫療保健領域生物樣本庫技術的進步
  • 市場挑戰
    • 組織銀行業務的局限性

波特五力：駕馭機構銀行市場的策略工具

波特的五力架構是了解組織銀行市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解機構銀行市場的外部影響

外部宏觀環境因素在塑造機構銀行市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解組織銀行市場的競爭狀況

對組織銀行市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 組織銀行市場供應商的定位矩陣績效評估

FPNV 定位矩陣是評估機構銀行市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃組織銀行市場的成功之路

組織銀行市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物樣本庫在世界各地不斷興起
      • 政府努力改善醫療機構的醫療設施
      • 移植醫學快速發展，人體組織應用不斷增加
    • 抑制因素
      • 在受控環境中保存生物組織的成本很高
    • 機會
      • 藥物分析的重大進展升級了組織保存
      • 醫療保健領域生物銀行技術的進步
    • 任務
      • 組織銀行業務的限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章組織銀行市場：依產品

  • 消耗品
  • 裝置

第7章 組織銀行市場：依應用分類

  • 化妝品
  • 醫學研究
  • 治療藥物

第8章 組織銀行市場：依最終使用者分類

  • 生物樣本庫
  • 醫院/診所
  • 研究/學術機構

第9章美洲的組織銀行市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太組織銀行市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的組織銀行市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BioKryo GmbH
  • Bluechiip Limited
  • Chernobyl Tissue Bank
  • Corning Incorporated
  • Eli Lilly & Company
  • Merck KGaA
  • Organ Recovery Systems, Inc.
  • Panasonic Corporation
  • PHC Holdings Corporation
  • QIAGEN NV
  • Sanofi SA
  • Taylor-Wharton International LLC
  • Thermo Fisher Scientific Inc.
  • VIVEX Biologics, Inc.
Product Code: MRR-03142C0401D3

The Tissue Banking Market was valued at USD 33.81 billion in 2023, expected to reach USD 37.13 billion in 2024, and is projected to grow at a CAGR of 9.91%, to USD 65.54 billion by 2030.

The scope and definition of tissue banking encompass the collection, processing, storage, and distribution of human tissues for therapeutic and research purposes. This process is crucial for applications in regenerative medicine, cancer treatment, and transplantation, as well as serving as a vital resource in biomedical research. Tissue banks play an essential role in ensuring the timely availability of tissues that meet quality and safety standards. The end-use scope includes hospitals, research institutes, and biopharmaceutical companies, each utilizing the tissues for their specific applications, ranging from direct patient care to advanced medical research and the development of novel therapies.

KEY MARKET STATISTICS
Base Year [2023] USD 33.81 billion
Estimated Year [2024] USD 37.13 billion
Forecast Year [2030] USD 65.54 billion
CAGR (%) 9.91%

Key growth factors influencing the tissue banking market include advancements in biotechnology, increasing demand for regenerative medicine, and the rising prevalence of chronic diseases necessitating advanced therapeutic solutions. Government initiatives promoting tissue-based research and increasing R&D investments by pharmaceutical companies further bolster this growth. Notable opportunities lie in expanding emerging markets, underscored by improving healthcare infrastructure and growing tissue donation awareness. To capitalize, businesses should focus on developing cost-effective and efficient tissue preservation techniques, enhancing the reliability of tissue-engineered products, and forming strategic partnerships with academic and research institutions.

Challenges affecting market growth include stringent regulatory frameworks governing tissue banking operations and ethical concerns related to tissue donation and usage. Technological hurdles in the preservation and long-term storage of tissues also pose significant challenges. Innovations in cryopreservation methods, automation in tissue processing, and development of bio-banking software for data management present promising areas for research and business growth.

The market is characterized by a complex interplay of regulatory and ethical considerations, mixed with rapid technological advancements. Thus, companies must prioritize compliance with regulatory standards while investing in cutting-edge research and development. Collaboration with regulatory bodies, investment in training, and public awareness campaigns about tissue donation are recommended strategies to foster market expansion and address current limitations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Banking Market

The Tissue Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of bio banks across the globe
    • Government initiatives by healthcare organizations to improvise healthcare facilities
    • Rapid development of transplant medicine and rise in applications of human tissue
  • Market Restraints
    • High-cost involved in preservation of biological tissues under controlled environments
  • Market Opportunities
    • Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
    • Advancements in biobanking technology in the healthcare sector
  • Market Challenges
    • Limitations of tissue banking

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Banking Market

A detailed market share analysis in the Tissue Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Banking Market

A strategic analysis of the Tissue Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Banking Market, highlighting leading vendors and their innovative profiles. These include Beckman Coulter, Inc., Bio-Rad Laboratories Inc., BioKryo GmbH, Bluechiip Limited, Chernobyl Tissue Bank, Corning Incorporated, Eli Lilly & Company, Merck KGaA, Organ Recovery Systems, Inc., Panasonic Corporation, PHC Holdings Corporation, QIAGEN N.V., Sanofi SA, Taylor-Wharton International LLC, Thermo Fisher Scientific Inc., and VIVEX Biologics, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Equipment.
  • Based on Application, market is studied across Cosmetics, Medical research, and Therapeutics.
  • Based on End User, market is studied across Biobanks, Hospitals & Clinics, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of bio banks across the globe
      • 5.1.1.2. Government initiatives by healthcare organizations to improvise healthcare facilities
      • 5.1.1.3. Rapid development of transplant medicine and rise in applications of human tissue
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost involved in preservation of biological tissues under controlled environments
    • 5.1.3. Opportunities
      • 5.1.3.1. Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
      • 5.1.3.2. Advancements in biobanking technology in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations of tissue banking
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Banking Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment

7. Tissue Banking Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetics
  • 7.3. Medical research
  • 7.4. Therapeutics

8. Tissue Banking Market, by End User

  • 8.1. Introduction
  • 8.2. Biobanks
  • 8.3. Hospitals & Clinics
  • 8.4. Research & Academic Institutes

9. Americas Tissue Banking Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Banking Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Banking Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Beckman Coulter, Inc.
  • 2. Bio-Rad Laboratories Inc.
  • 3. BioKryo GmbH
  • 4. Bluechiip Limited
  • 5. Chernobyl Tissue Bank
  • 6. Corning Incorporated
  • 7. Eli Lilly & Company
  • 8. Merck KGaA
  • 9. Organ Recovery Systems, Inc.
  • 10. Panasonic Corporation
  • 11. PHC Holdings Corporation
  • 12. QIAGEN N.V.
  • 13. Sanofi SA
  • 14. Taylor-Wharton International LLC
  • 15. Thermo Fisher Scientific Inc.
  • 16. VIVEX Biologics, Inc.

LIST OF FIGURES

  • FIGURE 1. TISSUE BANKING MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE BANKING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE BANKING MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE BANKING MARKET SIZE, BY MEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE BANKING MARKET SIZE, BY BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE BANKING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE BANKING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2023